Literature DB >> 7637748

Long-term course of neonatal diabetes.

K E von Mühlendahl1, H Herkenhoff.   

Abstract

BACKGROUND: Neonatal diabetes mellitus--defined here as hyperglycemia occurring within the first month of life that lasts for at least two weeks and requires insulin therapy--is a very rare form of the disease. Little is known about it, particularly with respect to its long-term course.
METHODS: We studied two brothers who had neonatal diabetes and obtained follow-up information on 34 patients described in the literature as well as information on 21 additional patients. Forty-seven of the patients had neonatal diabetes, as defined above, and in 10 others the onset was between the first and third month of life.
RESULTS: Twenty-six of the 57 infants had permanent diabetes, 18 had transient diabetes, and 13 had transient diabetes that recurred when they were 7 to 20 years old. Neonatal diabetes was associated with the Wolcott-Rallison syndrome in six infants, hyperuricemia due to phosphoribosyl-ATP pyrophosphatase hyperactivity in two, and celiac disease in two. Forty-one of 45 neonates in whom the duration of gestation and birth weight were known were small for their gestational ages. There were two pairs of affected twins and four other families with two or more infants with neonatal diabetes, but only three parents had diabetes. The incidence of neonatal diabetes mellitus in Germany has been estimated to be 1 in 500,000 neonates.
CONCLUSIONS: Neonatal diabetes differs from insulin-dependent diabetes in that its course is highly variable. Some patients have permanent diabetes, but others have transient or lasting remissions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637748     DOI: 10.1056/NEJM199509143331105

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  47 in total

1.  Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes.

Authors:  A L Gloyn; S Ellard; J P Shield; I K Temple; D J G Mackay; M Polak; T Barrett; A T Hattersley
Journal:  Diabetologia       Date:  2002-02       Impact factor: 10.122

Review 2.  New insights into the genetics of neonatal diabetes.

Authors:  Constantin Polychronakos
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

Review 3.  6q24 transient neonatal diabetes.

Authors:  I Karen Temple; Julian P H Shield
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

Review 4.  Diabetes mellitus in newborns and infants.

Authors:  P S Menon; U A Khatwa
Journal:  Indian J Pediatr       Date:  2000-06       Impact factor: 1.967

5.  Genomic imprinting in diabetes.

Authors:  Braxton D Mitchell; Toni I Pollin
Journal:  Genome Med       Date:  2010-08-23       Impact factor: 11.117

6.  Neonatal diabetes, with hypoplastic pancreas, intestinal atresia and gall bladder hypoplasia: search for the aetiology of a new autosomal recessive syndrome.

Authors:  J Mitchell; Z Punthakee; B Lo; C Bernard; K Chong; C Newman; L Cartier; V Desilets; E Cutz; I L Hansen; P Riley; C Polychronakos
Journal:  Diabetologia       Date:  2004-12-08       Impact factor: 10.122

Review 7.  Transient neonatal diabetes, a disorder of imprinting.

Authors:  I K Temple; J P H Shield
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

8.  Permanent neonatal diabetes mellitus - a case report of a rare cause of diabetes mellitus in East Africa.

Authors:  Catherine Nyangabyaki-Twesigye; Michael Rugambwa Muhame; Silver Bahendeka
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

9.  Neonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPF-1 Pro63fsX60 mutation.

Authors:  Inas H Thomas; Natinder K Saini; Amita Adhikari; Joyce M Lee; Josephine Z Kasa-Vubu; Delia M Vazquez; Ram K Menon; Ming Chen; Stefan S Fajans
Journal:  Pediatr Diabetes       Date:  2009-06-03       Impact factor: 4.866

10.  Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births.

Authors:  A S Slingerland; B M Shields; S E Flanagan; G J Bruining; K Noordam; A Gach; W Mlynarski; M T Malecki; A T Hattersley; S Ellard
Journal:  Diabetologia       Date:  2009-06-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.